DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID ▼ | Gene Name | UniProt ID |
---|---|---|---|---|---|
C0020538 | Hypertensive disease | SLC2A4 | 6517 | solute carrier family 2 member 4 | P14672 |
C0027765 | nervous system disorder | SLC2A4 | 6517 | solute carrier family 2 member 4 | P14672 |
C0020179 | Huntington Disease | SLC2A4 | 6517 | solute carrier family 2 member 4 | P14672 |
C0494463 | Alzheimer Disease, Late Onset | SLC2A4 | 6517 | solute carrier family 2 member 4 | P14672 |
C1332986 | Childhood Osteosarcoma | SLC2A4 | 6517 | solute carrier family 2 member 4 | P14672 |
C1510502 | Oxyphilic Adenoma | SLC2A4 | 6517 | solute carrier family 2 member 4 | P14672 |
C0024141 | Lupus Erythematosus, Systemic | SLC2A4 | 6517 | solute carrier family 2 member 4 | P14672 |
C0027051 | Myocardial Infarction | SLC2A4 | 6517 | solute carrier family 2 member 4 | P14672 |
C0031090 | Periodontal Diseases | SLC2A4 | 6517 | solute carrier family 2 member 4 | P14672 |
C0239946 | Fibrosis, Liver | SLC2A4 | 6517 | solute carrier family 2 member 4 | P14672 |
C0008497 | Choriocarcinoma | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
C0007137 | Squamous cell carcinoma | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
C0001418 | Adenocarcinoma | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
C1458155 | Mammary Neoplasms | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
C0006142 | Malignant neoplasm of breast | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
C0002395 | Alzheimer's Disease | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
C0007107 | Malignant neoplasm of larynx | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
C0684249 | Carcinoma of lung | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
C0027651 | Neoplasms | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
C1306459 | Primary malignant neoplasm | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
C0497327 | Dementia | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
C0152013 | Adenocarcinoma of lung (disorder) | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
C4721555 | Autoimmune hepatitis | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
C0678222 | Breast Carcinoma | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
C0040136 | Thyroid Neoplasm | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024